Photo of colorectal cancer

Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared on X:

“Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer (A-REPEAT study): efficacy and correlations with tissue and plasma genotyping – ESMO Gastrointestinal Oncology”

Authors: J. Sgouros,  A. Eliades, K. Papadopoulou, N. Korfiatis, D. Papamichael, E. Fountzilas, E. Tsolaki, A. Achilleos, K. Tsangaras, C. Loizides, G. Oikonomopoulos, T. Makatsoris, E. Kypri, M. Ioannides, G. Koumbaris, G. Fountzilas, P.C. Patsalis, G. Pentheroudakis

Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer

 

 

A. Achilleos A. Eliades Akhil Santhosh C. Loizides cancer D. Papamichael E. Fountzilas E. Kypri E. Tsolaki G Pentheroudakis G. Fountzilas G. Koumbaris G. Oikonomopoulos J. Sgouros K. Papadopoulou K. Tsangaras M. Ioannides N. Korfiatis OncoDaily Oncology P.C. Patsalis T. Makatsoris